300750 Contemporary Amperex Technology (A)

DGAP-News: IntelliCentrics Partners With Bridgewater in Home Healthcare Delivery

DGAP-News: Intellicentrics / Key word(s): Miscellaneous
IntelliCentrics Partners With Bridgewater in Home Healthcare Delivery

03.10.2019 / 09:03
The issuer is solely responsible for the content of this announcement.


Stockport, England--(Newsfile Corp. - October 3, 2019) - ​​​​​​​​​IntelliCentrics, creator of the SEC3URE Passport, which is used to digitally credential and privilege healthcare industry representatives so they can be trusted, and Bridgewater Community Healthcare NHS Foundation Trust (Bridgewater), a U.K. community health service provider, today announced a partnership that will provide IntelliCentrics technology to patients and their families at no cost. With the partnership, patients and families are able to trust the Bridgewater care provider by knowing who's entering their home, when, and his/her credentials.



IntelliCentrics Logo

To view an enhanced version of the logo, please visit:

"The SEC3URE Passport already ensures trust between all stakeholders across the entire continuum of care at over 11,000 locations across the UK and North America," said Mike Sheehan, CEO of IntelliCentrics. "The expansion of the SEC3URE Ethos into the home healthcare market is a natural next step for us. We are extremely excited to be launching this with Bridgewater."

The technology connects Bridgewater's home health practitioners and service providers with Bridgewater's patient customers, allowing the parties to establish bilateral trust. The patient customer will know who will be visiting, at what time, and the specific credentials of the healthcare practitioner before they arrive. Moreover, practitioners will have the opportunity to know more about the environment they will be entering so that they can provide the best possible care. "When high-quality care is delivered more deeply into our communities, everyone wins. And bilateral trust plays a very important role," said Michelle Collier, Procurement Manager of Bridgewater.

Rachael Colley, Head of Procurement Solutions and Innovation at NHS SBS, commented, "It is great to see new technology being developed with the Trust that so many other care organisations can now take advantage of. The new system ensures that patients are only contacted by professionals that are registered and approved contractors, which offers an enhanced level of patient protection and means patients can focus on getting the right care at the right time."

The partnership between Bridgewater, NHS SBS and IntelliCentrics is designed to ensure the home healthcare market enjoys the same proven technology used at over 11,000 locations of care across the U.K. and North America. This includes providing the technology free of charge to all of Bridgewater's patient community. "It's the right thing to do," said Collier.

About IntelliCentrics

With a mission to use trust to make high-quality healthcare as accessible as a good cup of coffee, IntelliCentrics created the SEC3URE Ethos. Built on three core principles - transparency, neutrality and independence, the SEC3URE Ethos is relied on by more than 11,000 locations worldwide to ensure two-way trust between patients, doctors, vendor representatives and healthcare companies. To learn more about the world's largest trusted healthcare technology platform, visit . IntelliCentrics is publicly traded on the Stock Exchange of Hong Kong Limited ("SEHK") under the stock code 6819.

About Bridgewater

Bridgewater Community Healthcare NHS Foundation Trust (Bridgewater) is a leading provider of community health services in the northwest of England. The majority of the services are delivered in patients' homes or at locations close to where they live, such as clinics, health centres, GP practices, community centres and schools. Bridgewater focuses on providing cost-effective NHS care by keeping people out of the hospital and supporting vulnerable people throughout their lives. For more information, visit .

Jonathon Squires
+44 (161) 2403201

To view the source version of this press release, please visit

169

Click on, or paste the following link into your web browser,to view the associated documents /release/48443
News Source: Newsfile


03.10.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at


Language: English
Company: Intellicentrics
United States
EQS News ID: 884885

 
End of News DGAP News Service

884885  03.10.2019 

fncls.ssp?fn=show_t_gif&application_id=884885&application_name=news&site_id=research_pool
EN
03/10/2019

Underlying

300750Contemporary Amperex Technology (A)

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Contemporary Amperex Technology (A)

 PRESS RELEASE

DGAP-News: ADL Bionatur Solutions Wins New Fermentation Client With Co...

DGAP-News: ADL Bionatur Solutions / Key word(s): Agreement ADL Bionatur Solutions Wins New Fermentation Client With Contract Revenues of EUR 20 Million 02.12.2019 / 09:06 The issuer is solely responsible for the content of this announcement. ADL BIONATUR SOLUTIONS WINS NEW FERMENTATION CLIENT WITH CONTRACT REVENUES OF EUR 20 MILLION The agreement with a leading Swiss biotech company includes technology transfer, upscaling and industrial-scale production of high value-added innovative ingredients for the cosmetics and nutrition industry ADL to apply its expertise in a...

 PRESS RELEASE

Admission of Security to Trading

NEX Exchange (NEXX) Admission of Security to Trading 02-Dec-2019 / 07:30 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. The following security will be admitted to trading on the NEX Exchange Growth Market with effect from 08:00, 02/12/2019. Name of Issuer: Dozens Savings Plc 5.00% Secured Bonds due 2 December 2020 ISIN: GB00BL1GTZ11  Symbol: DS04 EMS: 1 The Regulation Department NEX Exchange London Fruit & Wool Exchange 1 Duval Square London E1 6PW Tel: 020 7858 1655 Email:   W...

 PRESS RELEASE

Admission of Security to Trading

NEX Exchange (NEXX) Admission of Security to Trading 02-Dec-2019 / 07:30 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. The following security will be admitted to trading on the NEX Exchange Growth Market with effect from 08:00, 02/12/2019. Name of Issuer: SAPO PLC Ordinary Shares of GBP 0.01 ISIN: GB00B16GQJ90 Symbol: SAPO EMS: 5000 The Regulation Department NEX Exchange London Fruit & Wool Exchange 1 Duval Square London E1 6PW Tel: 020 7858 1655 Email:   Website: ...

 PRESS RELEASE

EQS-News: LIWET HOLDING AG publishes open letter to Dr. Martin Haefner...

EQS Group-News: Dynamics Group AG / Key word(s): Statement/Corporate Action LIWET HOLDING AG publishes open letter to Dr. Martin Haefner in various Swiss Sunday newspapers 01.12.2019 / 05:59 Open letter to Dr. Martin Haefner Dear Mr Haefner We share your concern about the future of Schmolz+Bickenbach (S+B). The company urgently needs money, everyone - including Liwet - agrees. However, there is still time to find a constructive solution for S+B that is in the interest of all, not only one particular shareholder. Liwet is ready to rescue the company and the 10,000 jobs. Liw...

 PRESS RELEASE

EQS-News: LIWET HOLDING AG publiziert offenen Brief an Dr. Martin Haef...

EQS Group-News: Dynamics Group AG / Schlagwort(e): Stellungnahme/Kapitalmaßnahme LIWET HOLDING AG publiziert offenen Brief an Dr. Martin Haefner in verschiedenen Schweizer Sonntagszeitungen 01.12.2019 / 05:59 Offener Brief an Dr. Martin Haefner Sehr geehrter Herr Haefner Wir teilen Ihre Sorge um die Zukunft von Schmolz+Bickenbach (S+B). Die Firma braucht dringend Geld; damit sind alle - auch Liwet - einverstanden. Noch bleibt Zeit, um eine konstruktive Lösung für S+B zu finden, die im Interesse aller Aktionäre ist, nicht nur eines einzigen. Liwet steht bereit, die Fir...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch